Cargando…
Understanding the Molecular Mechanisms of Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD): Towards the Development of SSADH-Targeted Medicine
Succinic semialdehyde dehydrogenase deficiency (SSADHD) is a rare genetic disorder caused by inefficient metabolic breakdown of the major inhibitory neurotransmitter, γ-aminobutyric acid (GABA). Pathologic brain accumulation of GABA and γ-hydroxybutyrate (GHB), a neuroactive by-product of GABA catab...
Autores principales: | Lee, Henry H. C., McGinty, Gabrielle E., Pearl, Phillip L., Rotenberg, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910003/ https://www.ncbi.nlm.nih.gov/pubmed/35269750 http://dx.doi.org/10.3390/ijms23052606 |
Ejemplares similares
-
OCD symptoms in succinic semialdehyde dehydrogenase (SSADH) deficiency: a case report
por: Phakey, Sachin, et al.
Publicado: (2020) -
In vitro modeling of experimental succinic semialdehyde dehydrogenase deficiency (SSADHD) using brain-derived neural stem cells
por: Vogel, Kara R., et al.
Publicado: (2017) -
A Missense Variant in ALDH5A1 Associated with Canine Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD) in the Saluki Dog
por: Vernau, Karen M., et al.
Publicado: (2020) -
Targeted screening of succinic semialdehyde dehydrogenase deficiency (SSADHD) employing an enzymatic assay for γ-hydroxybutyric acid (GHB) in biofluids
por: Wernli, C., et al.
Publicado: (2016) -
Neurotransmitter alterations in embryonic succinate semialdehyde dehydrogenase (SSADH) deficiency suggest a heightened excitatory state during development
por: Jansen, Erwin EW, et al.
Publicado: (2008)